Melissa Stamm

  • Vanderbilt University

    Colon cancer’s cellular crossroads

    New information about signaling pathways involved in colorectal cancer could aid in assessing prognosis and identifying new therapeutic targets for the disease. Read More

    Mar 16, 2012

  • Vanderbilt University

    Urine biomarker for colon cancer?

    A molecule detectable in urine may be helpful in diagnosing colon cancer. Read More

    Mar 10, 2012

  • Vanderbilt University

    Combo combats dizziness

    Some patients may need a combo of medications to combat a condition that causes dizziness. Read More

    Mar 9, 2012

  • Vanderbilt University

    ‘Acid test’ for cervical cancer

    An inexpensive, low-tech test for cervical cancer may be a good option for screening for the disease among HIV-infected women in developing countries. Read More

    Feb 21, 2012

  • Vanderbilt University

    On the tail of RSV infection mechanism

    New details about the life cycle of respiratory syncytial virus (RSV) could aid the development of therapies to combat this leading cause of serious illness in infants and the elderly. Read More

    Feb 15, 2012

  • Vanderbilt University

    Treatment window for genetic disorder

    Treatment with a drug used to prevent organ rejection partially reverses the course of tuberous sclerosis, research in mice suggests. Read More

    Feb 1, 2012

  • Vanderbilt University

    Drugs reverse lung cancer cell changes

    Drugs that target “epigenetic” changes may help treat or slow the progression of lung cancer. Read More

    Feb 1, 2012

  • Vanderbilt University

    Protein repairs esophageal DNA damage

    A protein involved in repairing DNA damage associated with gastric reflux may play a tumor suppressor role in the esophagus and could represent a target for therapies to combat esophageal cancer. Read More

    Jan 25, 2012

  • Vanderbilt University

    Obesity genes linked to uterine cancer

    In addition to body mass index, genetic markers of obesity may provide value in predicting endometrial cancer risk. Read More

    Jan 20, 2012

  • Vanderbilt University

    Stanford’s Südhof to speak on synapse development, function

    Thomas Südhof, M.D., the Avram Goldstein Professor of Molecular and Cellular Physiology at Stanford University School of Medicine, will deliver the first Discovery Lecture of 2012 on Thursday, Jan. 12. Thomas Südhof, M.D. His talk, “Neurexins: from synapse formation to synapse function,” will begin… Read More

    Jan 5, 2012

  • Vanderbilt University

    Green tea totals colorectal cancer

    Tea and its phytochemical constituents have demonstrated anti-cancer properties in cell and animal experiments – particularly green tea, which has higher levels of antioxidant polyphenols than other types of tea. iStockphoto.com Gong Yang, M.D., MPH, and colleagues evaluated the association between green tea consumption and colorectal cancer risk in participants… Read More

    Jan 5, 2012

  • Cell in mitosis

    Divvying up chromosomes

    (Benedict Campbell/Wellcome Images) Mitosis, or the separation of chromosomes during cell division, is driven by dynamic interactions between the kinetochore region on chromosomes and string-like structures called microtubules. A number of proteins, including the enzyme Cdk1, regulate these interactions, but it is unclear what kinetochore components such enzymes work… Read More

    Dec 16, 2011

  • Vanderbilt University

    Divvying up chromosomes

    Protein helps ensure proper division of chromosomes during cell division. Read More

    Dec 15, 2011

  • Vanderbilt University

    Virus-linked cancer gets help from host

    Host cell protein may be a target for strategies to limit spread of virus-induced squamous cell cancers. Read More

    Dec 15, 2011

  • scalpel

    Lung nodule surgery not always “futile”

    Even when lung operations for suspected cancer resection results in a benign diagnosis, there still may be significant benefits to the procedure, new research suggests. Read More

    Dec 7, 2011

  • Illustration of human intestinal tract

    Pathway to colon cancer progression

    Molecular players involved in colon cancer progression could provide new biomarkers to indicate invasiveness and prognosis. Read More

    Dec 1, 2011

  • Vanderbilt University

    Exercise fights fatty liver

    (iStock) Fatty liver, a reversible condition of fat accumulation in liver cells, can result from excessive alcohol consumption, obesity, type 2 diabetes, or metabolic disorders. Exercise can reverse this process, but the mechanisms underlying this effect are not clear. Because exercise is known to stimulate the action of glucagon (a… Read More

    Nov 18, 2011

  • Cancer researchers in lab

    Protein family key to aging linked to suppressing tumors

    The list of aging-associated proteins known to be involved in cancer is growing longer, according to research by investigators at Vanderbilt-Ingram Cancer Center and the National Institutes of Health. Read More

    Oct 28, 2011

  • Colitis

    Stopping colitis, STAT

    Study suggests a new therapeutic target in ulcerative colitis. Read More

    Oct 27, 2011

  • Vanderbilt University

    Growth factor boosts beta cells

    A growth factor may help grow transplantation-quality pancreas cells for treating diabetes. Read More

    Oct 21, 2011